Validation of a genomic-clinical classifier for predicting clinical progression in high-risk prostate cancer.
Christine Buerki
Employment or Leadership Position - GenomeDx Biosciences
Anirban Pradip Mitra
No relevant relationships to disclose
Peter C. Black
Consultant or Advisory Role - GenomeDx Biosciences (U)
Research Funding - GenomeDx Biosciences
Mercedeh Ghadessi
Employment or Leadership Position - GenomeDx Biosciences
Eric J. Bergstralh
No relevant relationships to disclose
Nicholas Erho
Employment or Leadership Position - GenomeDx Biosciences
Rachel Carlson
No relevant relationships to disclose
Anamaria Crisan
Employment or Leadership Position - GenomeDx Biosciences
Thomas Sierocinski
Employment or Leadership Position - GenomeDx Biosciences
Benedikt Zimmermann
Employment or Leadership Position - GenomeDx Biosciences
Zaid Haddad
Employment or Leadership Position - GenomeDx Biosciences
Ismael A. Vergara
Employment or Leadership Position - GenomeDx Biosciences
Karla V. Ballman
No relevant relationships to disclose
George G. Klee
Employment or Leadership Position - Mayo Clinic
Research Funding - NIH Mayo Prostate SPORE
Stephanie Fink
No relevant relationships to disclose
Thomas M. Kollmeyer
No relevant relationships to disclose
Timothy J. Triche
Employment or Leadership Position - GenomeDx Biosciences
Consultant or Advisory Role - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
Elai Davicioni
Employment or Leadership Position - GenomeDx Biosciences
Stock Ownership - GenomeDx Biosciences
R. Jeffrey Karnes
No relevant relationships to disclose
Robert B. Jenkins
Research Funding - Genome Diagnostics